
Sign up to save your podcasts
Or
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
4.8
129129 ratings
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
130 Listeners
289 Listeners
325 Listeners
45 Listeners
492 Listeners
14 Listeners
87 Listeners
21 Listeners
185 Listeners
340 Listeners
515 Listeners
348 Listeners
182 Listeners
366 Listeners
77 Listeners